Consumption coagulopathy in acute aortic dissection: principles of management

J Cardiothorac Surg. 2017 Jun 12;12(1):50. doi: 10.1186/s13019-017-0613-5.

Abstract

Background: The effect of acute aortic dissection itself on coagulopathy or surgery-related coagulopathy has never been specifically studied. The aim of the present study was to perioperatively describe consumption coagulopathy in patients with acute aortic dissection.

Methods: Sixty-six patients with acute type A aortic dissection were enrolled in this study from January 2015 to September 2016. Thirty-six patients with thoracic aortic aneurysms were used as a control group during the same period. Consumption coagulopathy was evaluated using standard laboratory tests, enzyme-linked immunosorbent assay and thromboelastograghy at five perioperative time-points.

Results: A significant reduction in clotting factors and fibrinogen was observed at the onset of acute aortic dissection. Enzyme-linked immunosorbent assay and thromboelastograghy also revealed a persistent systemic activation of the coagulation system and the consumption of clotting factors. In contrast, although platelet counts were consistently low, we did not find that platelet function was more impaired in the acute aortic dissection group than the control group.

Conclusions: After surgery, clotting factors and fibrinogen were more impaired than platelet function. Thus, we proposed that hemostatic therapy should focus on the rapid and sufficient supplementation of clotting factors and fibrinogen to improve consumption coagulopathy in patients with acute aortic dissection.

Keywords: Acute aortic dissection; Clotting factors; Consumption coagulopathy; Fibrinogen; Platelets.

MeSH terms

  • Aortic Aneurysm, Thoracic / diagnosis
  • Aortic Aneurysm, Thoracic / surgery*
  • Aortic Dissection / diagnosis
  • Aortic Dissection / surgery*
  • Blood Coagulation Disorders / blood
  • Blood Coagulation Disorders / etiology*
  • Blood Coagulation Disorders / therapy
  • Blood Coagulation Tests
  • Blood Coagulation*
  • Blood Vessel Prosthesis Implantation / adverse effects*
  • Disease Management*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fibrinogen / metabolism*
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Platelet Count
  • Prospective Studies

Substances

  • Fibrinogen